A Phase II Open-label Multicenter Study to Assess the Efficacy and Safety of AFM13 in Patients with Relapsed or Refractory CD30-positive Peripheral T-cell Lymphoma or Transformed Mycosis Fungoides (RE-DIRECT)

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date28/11/1927/11/24

Keywords

  • clinical trial
  • phase 2 study
  • lymphoma
  • treatment efficacy
  • treatment safety